- |||||||||| goserelin acetate / Generic mfg., leuprolide acetate for depot suspension / Generic mfg.
Trial completion: Bipolar Androgen-based Therapy for Prostate Cancer (BAT) (clinicaltrials.gov) - Aug 25, 2015 P2, N=33, Completed, Active, not recruiting --> Completed | Trial primary completion date: Dec 2014 --> Sep 2014 Active, not recruiting --> Completed
- |||||||||| leuprolide acetate for depot suspension / Generic mfg., everolimus / Generic mfg., bicalutamide / Generic mfg.
Trial completion, Monotherapy, Metastases: Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer (clinicaltrials.gov) - Aug 12, 2015 P1, N=30, Completed, Phase classification: P2/3 --> P2 Recruiting --> Completed
- |||||||||| Yervoy (ipilimumab) / Ono Pharma, BMS
Trial primary completion date, IO biomarker: Neoadjuvant Ipilimumab in Prostate Cancer (clinicaltrials.gov) - Jul 6, 2015 P2a, N=20, Active, not recruiting, Not yet recruiting --> Active, not recruiting | Initiation date: Sep 2014 --> Dec 2014 Trial primary completion date: Sep 2015 --> Sep 2016
- |||||||||| leuprolide acetate for depot suspension / Generic mfg.
Trial primary completion date: Effects of Estrogen Deficiency on Energy Expenditure (clinicaltrials.gov) - Jun 11, 2015 P=N/A, N=12, Recruiting, Initiation date: Feb 2015 --> Nov 2015 Trial primary completion date: May 2015 --> May 2016
- |||||||||| leuprolide acetate for depot suspension / Generic mfg., docetaxel / Generic mfg.
Trial primary completion date: A Registry for Patients Treated on the Clinical Trial TAX 3503 (clinicaltrials.gov) - Jun 11, 2015 P3, N=19, Enrolling by invitation, Trial primary completion date: May 2015 --> May 2016 Trial primary completion date: Mar 2015 --> Mar 2016
- |||||||||| leuprolide acetate for depot suspension / Generic mfg.
Trial primary completion date: DUALTRIGGER: Study of Dual Trigger Ovulation in Oocyte Donors (clinicaltrials.gov) - Jun 11, 2015 P4, N=180, Recruiting, Trial primary completion date: Mar 2015 --> Mar 2016 Trial primary completion date: Jun 2014 --> Jun 2016
- |||||||||| docetaxel / Generic mfg.
Trial completion, Trial initiation date, Trial primary completion date: Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer (clinicaltrials.gov) - Jun 9, 2015 P2, N=40, Completed, Trial primary completion date: Jun 2014 --> Jun 2016 Active, not recruiting --> Completed | Initiation date: May 2008 --> May 2005 | Trial primary completion date: May 2016 --> Jun 2015
- |||||||||| Climara (estradiol) / Bausch Health, Bayer
Trial completion, Enrollment change: POWER: Prevention of Obesity in Women Via Estradiol Regulation (clinicaltrials.gov) - May 27, 2015 P3, N=150, Completed, Active, not recruiting --> Completed | Initiation date: May 2008 --> May 2005 | Trial primary completion date: May 2016 --> Jun 2015 Recruiting --> Completed | N=300 --> 150
- |||||||||| leuprolide acetate for depot suspension / Generic mfg.
Trial completion, Trial initiation date: Leuprolide in Determining the Cause of Gonadotropin Deficiency (clinicaltrials.gov) - Mar 25, 2015 P=N/A, N=90, Completed, Recruiting --> Completed Recruiting --> Completed | Initiation date: Dec 1999 --> Aug 1994
- |||||||||| Orgovyx (relugolix) / Intas, Gedeon Richter, Takeda, ASKA Pharma, Sumitomo Pharma, Pfizer
Enrollment closed: A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer (clinicaltrials.gov) - Feb 27, 2015 P2, N=125, Active, not recruiting, Trial primary completion date: Feb 2015 --> Feb 2016 Recruiting --> Active, not recruiting
- |||||||||| letrozole / Generic mfg., leuprolide acetate for depot suspension / Generic mfg., everolimus / Generic mfg.
Enrollment closed: Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) (clinicaltrials.gov) - Feb 12, 2015 P2, N=84, Active, not recruiting, Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||||||||| Firmagon (degarelix) / Astellas, Ferring
Trial primary completion date: Degarelix in the Treatment of Endometriosis Recurrence (clinicaltrials.gov) - Feb 5, 2015 P3, N=100, Recruiting, Recruiting --> Completed Trial primary completion date: Aug 2014 --> Jul 2015
- |||||||||| Herceptin (trastuzumab) / Roche, Kisqali (ribociclib) / Novartis, Perjeta (pertuzumab) / Roche
New P3 trial, Combination therapy, Metastases: Detect V / CHEVENDO (Chemo vs. Endo) (clinicaltrials.gov) - Jan 26, 2015 P3, N=270, Not yet recruiting,
- |||||||||| goserelin acetate / Generic mfg., leuprolide acetate for depot suspension / Generic mfg.
Trial primary completion date: Bipolar Androgen-based Therapy for Prostate Cancer (BAT) (clinicaltrials.gov) - Dec 30, 2014 P2, N=33, Active, not recruiting, N=600 --> 912 Trial primary completion date: Jan 2015 --> Jun 2015
- |||||||||| leuprolide acetate for depot suspension / Generic mfg.
Trial primary completion date: Effects of Estrogen Deficiency on Energy Expenditure (clinicaltrials.gov) - Dec 5, 2014 P=N/A, N=12, Recruiting, Recruiting --> Active, not recruiting Trial primary completion date: May 2014 --> May 2015
|